|
Quotes & Info
|
| HOLX > SEC Filings for HOLX > Form 8-K on 9-Nov-2009 | All Recent SEC Filings |
9-Nov-2009
Results of Operations and Financial Condition, Change in Directors or Principal Offic
On November 9, 2009, the Company issued a press release announcing its financial results for the fourth quarter and year ended September 26, 2009. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein in its entirety by reference.
Limitation on Incorporation by Reference. The information furnished in this Item 2.02, including the above-referenced press release, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.
Cautionary Note Regarding Forward-Looking Statements. The press release contains forward-looking statements which involve certain risks and uncertainties that could cause actual results to differ materially from those expressed or implied by these statements. Please refer to the cautionary note in the press release regarding these forward-looking statements.
Appointment of New Chief Executive Officer. On November 5, 2009, the Board of Directors of Hologic, Inc. (the "Company") appointed Robert Cascella, its President and Chief Operating Officer, to the position of President and Chief Executive Officer. John Cumming, our former Chairman and Chief Executive Officer, has agreed to remain with the Company as Chairman and an executive officer. As Chairman it is anticipated that Mr. Cumming will focus on developing new business and international expansion. Certain biographical information regarding Mr. Cascella is included in the Company's Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission (the "SEC") on January 22, 2009, and is incorporated herein by reference.
Transition Agreement. In connection with the Company's leadership change, the Company entered into a Transition Agreement with Mr. Cumming. The Transition Agreement has an initial term expiring on December 31, 2011 and provides that commencing on the effective date of that agreement, November 5, 2009 (the "Effective Date"), Mr. Cumming will be employed as Chairman and an executive officer of the Company.
Initial Compensation. As of the Effective Date, the Transition Agreement reduced
Mr. Cumming's annual base salary to $725,000 per year. In addition, subject to
the terms of each applicable plan and in accordance with the terms and
conditions of the agreement, the agreement provides that Mr. Cumming will
continue to be eligible to participate in the Company's Short-Term Incentive
Plan, Supplemental Executive Retirement Plan, equity incentive plan, health and
welfare benefit plans, qualified retirement plans and such other perquisites as
offered to other officers of the Company. The agreement further provides that
(i) for so long as Mr. Cumming remains employed as an executive officer on a
full-time basis, during the Company's 2010 and 2011 fiscal years, his target
Transition and Retention Payments. In consideration of Mr. Cumming's agreement to relinquish his position as Chief Executive Officer, and forego his right to terminate his employment and receive severance benefits under his Retention and Severance Agreement (described below), the Company agreed to pay Mr. Cumming a transition payment of $1.75 million. In addition, the Transition Agreement provides that so long as Mr. Cumming has remained continuously employed by the Company from the Effective Date to the one year anniversary thereof, then the Company will pay Mr. Cumming a retention payment in the amount of $1.725 million; and if Mr. Cumming has remained continuously employed by the Company through the two year anniversary of the Effective Date, then the Company will pay Mr. Cumming an additional retention payment in the amount of $1.725 million (collectively, with the first retention payment, the "Retention Payments").
Termination of Employment. The Transition Agreement provides that Mr. Cumming shall continue to be an employee at will and that, subject to the terms and conditions of the Agreement, the Company retains the right, at any time, to terminate Mr. Cumming's employment.
In the event that the Company terminates Mr. Cumming's employment other than for Cause (as defined), Mr. Cumming resigns for Good Reason (as defined; either such termination, an "Involuntary Termination"), or Mr. Cumming's employment is terminated as a result of his death or permanent disability, Mr. Cumming will be entitled to the following benefits under the Transition Agreement:
• his accrued compensation and benefits through the date of termination (the "Accrued Benefits");
• a pro rata bonus for the year based upon his target bonus;
• acceleration of any retention payments not yet made;
• notwithstanding any other provisions to the contrary contained in any equity award agreement, from and after the Effective Date through the Termination Date, the Company shall vest Mr. Cumming in each equity award that was outstanding and unvested as of the Effective Date in equal monthly installments over the remaining vesting term (measured from the Effective Date) of such Equity Award, but not less than would have otherwise vested under the equity award as of the Termination Date; and
• the right to exercise any stock options or other equity awards that are then vested, for a period of up to one year following his termination; provided, however, that the exercise period may not extend beyond the remaining term of each applicable award.
Following the initial two year term of the Transition Agreement, Mr. Cumming will be entitled to six months notice of any Involuntary Termination. No benefits are payable to Mr. Cumming under the Transition Agreement on the Company's termination of Mr. Cumming's employment for Cause (as defined) or Mr. Cumming's voluntary termination of his employment. If so requested by the Board, upon termination of Mr. Cumming's employment for any reason, Mr. Cumming is also required to resign from the Company's Board of Directors.
Termination of Prior Agreements. The Transition Agreement replaces the Retention and Severance Agreement and the Change of Control Agreement (both described in further detail below) previously entered into between the Company and Mr. Cumming. As a result, the Company no longer has any further obligations under either of these agreements.
Under the Retention and Severance Agreement Mr. Cumming was entitled to receive certain benefits, including one times his previous year's salary and bonus upon a termination of his employment by the Company or his resignation for good reason, as well as certain other benefits.
Under the Change of Control Agreement, Mr. Cumming was entitled to receive significant benefits after a change of control of the Company while he remained employed by the Company. The benefits included the payment of cash in an amount equal to Mr. Cumming's annual salary for the fiscal year immediately preceding the change of control plus his Highest Annual Bonus (as defined), multiplied by three. In addition, the agreement provided that upon a change of control all unvested equity awards would vest. In addition, if Mr. Cumming remained employed through the first anniversary of a change of control, then he would have been paid a special bonus equal to the sum of the executive's annual salary and Highest Annual Bonus. The agreement also provided for a full gross up on any special excise taxes that would have been imposed on the change of control benefits. In connection with the Company's business combination with Cytyc, Mr. Cumming agreed to amend his Change of Control Agreement to waive his right to receive any change of control benefits in connection with that transaction, provided that his employment was not Involuntarily Terminated prior to October 22, 2009.
. . .
Effective November 5, 2009, the Board of Directors amended the Company's Second Amended and Restated By-laws, as amended (the "By-laws"). The revisions, among other things, provide that the Company's Lead Independent Director shall preside over the Company's meetings of its Board of Directors.
The description above is a summary of the terms of the amendments to the Company's By-laws. This description does not purport to be complete and it is qualified in its entirety by reference to the Company's By-laws, as amended, a copy of which is attached to this report as Exhibit 3.1 and is incorporated herein in its entirety by reference.
(d) Exhibits.
The following exhibits are filed herewith:
3.1 Second Amended and Restated By-laws, as amended
10.1 Transition Agreement
99.1 Press Release
|
|